<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Юга России</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Herald of the South of Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2015-4-55-60</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-262</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>РОЛЬ ВАЗОРЕГУЛЯТОРНЫХ ФАКТОРОВ ЭНДОТЕЛИЯ В РАЗВИТИИ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ ПРИ ХРОНИЧЕСКОМ СТРЕССЕ</article-title><trans-title-group xml:lang="en"><trans-title>THE PLACE OF THE ENDOTHELIAL VASOREGULATION FACTORS IN THE FORMATION OF THE HYPERTENSION IN CONDITION OF THE CHRONIC STRESS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Луцкий</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Lutskyy</surname><given-names>I. S.</given-names></name></name-alternatives><email xlink:type="simple">contact@dsmu.dnmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зяблицев</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ziablices</surname><given-names>S. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кишеня</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kishenia</surname><given-names>M. S.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лютикова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Liutykova</surname><given-names>L. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернобривцев</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernobrivec</surname><given-names>P. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Донецкий национальный медицинский университет им. М. Горького</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Donetsk National Medical University of Maxim Gorky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2015</year></pub-date><volume>0</volume><issue>4</issue><fpage>55</fpage><lpage>60</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Луцкий И.С., Зяблицев С.В., Кишеня М.С., Лютикова Л.В., Чернобривцев П.А., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Луцкий И.С., Зяблицев С.В., Кишеня М.С., Лютикова Л.В., Чернобривцев П.А.</copyright-holder><copyright-holder xml:lang="en">Lutskyy I.S., Ziablices S.V., Kishenia M.S., Liutykova L.V., Chernobrivec P.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/262">https://www.medicalherald.ru/jour/article/view/262</self-uri><abstract><sec><title>Цель</title><p>Цель: оценить роль вазоактивных факторов эндотелия (оксида азота (NO) и эндотелина 1 (ЭТ-1)) в формировании артериальной гипертензии (АГ) в условиях действия хронического стресса (ХС).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: обследовано 160 машинистов магистральных локомотивов (ММЛ) со стажем работы от 1 года до 35 лет. В качестве контроля обследовали 100 практически здоровых волонтеров. Для оценки состояния стрессорной системы (СС) определяли содержание в крови адренокортикотропного гормона, кортизола и кортикостерона.</p></sec><sec><title>Результаты</title><p>Результаты: действие ХС сопровождается этапной реакцией со стороны СС:  периодами активации, адаптации и дезадаптации. В периоды активации и адаптации отмечалось повышение синтеза NO на фоне умеренного роста содержания ЭТ-1. Период дезадаптации сопровождался снижением продукции NO и двукратным увеличением уровней ЭТ-1, увеличением толщины комплекса интима-медия общих сонных артерий (свидетельство процессов ремоделирования сосудов). Недостаточный синтез вазодилататоров, избыточное образование вазоконстрикторов, ремоделирование сосудистой стенки способствовали формированию, течению и прогрессированию АГ.</p></sec><sec><title>Вывод</title><p>Вывод: полученные данные позволяют уточнить патогенетические механизмы формирования АГ в условиях действия ХС.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: the assessment of place of the endothelial vasoregulation factors (nitrogen oxide (no) and endothelin 1 (et-1)) in the formation of the arterial hypertension (AH) in condition of chronic stress (CS) was held.</p></sec><sec><title>Materials and methods</title><p>Materials and methods: 160 railroad engineers (RRE) were examined. They had work experience from 1 to 35 years. As controls, 100 healthy volunteers wereexamined. The level of adrenocorticotropic hormone, cortisol and corticosterone in the blood as a condition of the stress system (SS) were measured.</p></sec><sec><title>Results</title><p>Results: it was found out that the effect of stress reaction is accompanied by the serial reaction of the SS: activation period, adaptation and disadaptation. In the activation and the adaptation periods was marked increase synthesis of NO against the background moderate increase of ET-1 concentration. The disadaptation period was accompanied by decrease in NO production and doubling the level of ET-1, an increase of the thickness of the carotid intima-media complex (as evidence of vascular remodeling processes). Insufficient synthesis of the vasodilators, excessive production of the vasoconstrictors, remodeling of the vascular wall contributed to the formation, process and progression of the hypertension.</p></sec><sec><title>Conclusion</title><p>Conclusion: these results specify the pathogenic mechanisms of AH in condition of CS.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>хронический стресс</kwd><kwd>оксид азота</kwd><kwd>эндотелин</kwd><kwd>эндотелиальная дисфункция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>chronic stress</kwd><kwd>nitrogen oxide</kwd><kwd>endothelin</kwd><kwd>endothelialdysfunction</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Adhikari S. Epidemiology ofelevated blood pressure in the ED // Am. J.Emerg.Med. 2014. Vol. 32(11). P. 1370-1372.</mixed-citation><mixed-citation xml:lang="en">Adhikari S. Epidemiology ofelevated blood pressure in the ED // Am. J.Emerg.Med. 2014. Vol. 32(11). P. 1370-1372.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Попова А.А. Эндотелиальная дисфункция и механизмы ее формирования // Сибирское медицинское обозрение. 2013. Т.64, N 4. С. 7-19.</mixed-citation><mixed-citation xml:lang="en">Попова А.А. Эндотелиальная дисфункция и механизмы ее формирования // Сибирское медицинское обозрение. 2013. Т.64, N 4. С. 7-19.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Brandes R.P. Endothelial dysfunction and hypertension // Hypertension. – 2014. – Т.64, N. 5. – P. 924-928.</mixed-citation><mixed-citation xml:lang="en">Brandes R.P. Endothelial dysfunction and hypertension // Hypertension. – 2014. – Т.64, N. 5. – P. 924-928.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Гайнуллина Д.К. Оксид азота в эндотелии сосудов: регуляция продукции и механизмы действия // Успехи физиологических наук. 2013. Т. 44, N 4. С. 88-102.</mixed-citation><mixed-citation xml:lang="en">Гайнуллина Д.К. Оксид азота в эндотелии сосудов: регуляция продукции и механизмы действия // Успехи физиологических наук. 2013. Т. 44, N 4. С. 88-102.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Garaline V. Endothelium and nitric oxide // Medicina. 2008. Vol. 44. P. 564-569.</mixed-citation><mixed-citation xml:lang="en">Garaline V. Endothelium and nitric oxide // Medicina. 2008. Vol. 44. P. 564-569.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sandoval Y.H. Endothelin-1 signaling in vascular physiology and pathophysiology // Curr.Vasc.Pharmacol. 2014. Vol. 12(2). P. 202- 214.</mixed-citation><mixed-citation xml:lang="en">Sandoval Y.H. Endothelin-1 signaling in vascular physiology and pathophysiology // Curr.Vasc.Pharmacol. 2014. Vol. 12(2). P. 202- 214.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Marković V.M. Predictive modeling of the hypothalamic-pituitaryadrenal (HPA) axis response to acute and chronic stress // Endocr. J. 2011. Vol. 58(10). P. 89-904.</mixed-citation><mixed-citation xml:lang="en">Marković V.M. Predictive modeling of the hypothalamic-pituitaryadrenal (HPA) axis response to acute and chronic stress // Endocr. J. 2011. Vol. 58(10). P. 89-904.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou Y. Endothelin-1-induced responses in isolated mouse vessels: the expression and function of receptor types //Am. J.Physiol. Heart.Circ.Physiol. 2004. Vol. 287(2). – P. 573-578.</mixed-citation><mixed-citation xml:lang="en">Zhou Y. Endothelin-1-induced responses in isolated mouse vessels: the expression and function of receptor types //Am. J.Physiol. Heart.Circ.Physiol. 2004. Vol. 287(2). – P. 573-578.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Goch A.Endothelial dysfunction in patients with noncomplicated and complicated hypertension // Clin.Exp.Hypertens. 2009. T. 31(1). P. 20-30.</mixed-citation><mixed-citation xml:lang="en">Goch A.Endothelial dysfunction in patients with noncomplicated and complicated hypertension // Clin.Exp.Hypertens. 2009. T. 31(1). P. 20-30.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Huang B.S. Role of brain corticosterone and aldosteroneincentra l angiotensin II-induced hypertension // Hypertension. 2013. T. 62(3). P. 564-571.</mixed-citation><mixed-citation xml:lang="en">Huang B.S. Role of brain corticosterone and aldosteroneincentra l angiotensin II-induced hypertension // Hypertension. 2013. T. 62(3). P. 564-571.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Коноплева Л.Ф.Эндотелиальная дисфункция в патогенезе сердечно сосудистых заболеваний и методы ее коррекции // Therapia. 2011. Т.56(3). С.26-30.</mixed-citation><mixed-citation xml:lang="en">Коноплева Л.Ф.Эндотелиальная дисфункция в патогенезе сердечно сосудистых заболеваний и методы ее коррекции // Therapia. 2011. Т.56(3). С.26-30.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
